Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.256
-$0.005-1.92%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -52.11% | 97.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -41.76% | 105.83% | |||
| Operating Income | 41.76% | -105.83% | |||
| Income Before Tax | 57.76% | -86.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 57.76% | -86.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 57.76% | -86.30% | |||
| EBIT | 41.76% | -105.83% | |||
| EBITDA | 41.81% | -105.90% | |||
| EPS Basic | 79.50% | -64.48% | |||
| Normalized Basic EPS | 74.44% | -31.17% | |||
| EPS Diluted | 74.79% | -64.48% | |||
| Normalized Diluted EPS | 74.44% | -31.17% | |||
| Average Basic Shares Outstanding | 106.04% | 13.27% | |||
| Average Diluted Shares Outstanding | 106.04% | 13.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||